Patient info Open main menu

B02AA02 tranexamic acid

ATC group of level 5 – chemical substance · in plain English: medicines to stop bleeding

This site has the patient leaflet or the SPC of 13 medicines in this group.

Active substance: Tranexamic acid – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. B Blood and blood forming organ drugs 1,013 medicines
    1. B02 Antihemorrhagics 196 medicines
      1. B02A Antifibrinolytics 15 medicines
        1. B02AA Antifibrinolytic amino acids 13 medicines
          1. B02AA02 tranexamic acid 13 medicines

Medicines

MedicineLegal category
Cyklokapron 500 mg film-coated tablets SPC no longer supplied –
Cyklokapron 500 mg solution for injection SPC Prescription only (POM)
Tranexamic Acid 10 mg/ml solution for infusion SPC –
Tranexamic Acid 100 mg / ml solution for injection Prescription only (POM)
Tranexamic Acid 100 mg / ml solution for injection/infusion SPC –
Tranexamic Acid 100 mg/ml oral solution SPC –
Tranexamic Acid 1000 mg coated granules in sachet Prescription only (POM)
Tranexamic Acid 500 mg / 5 ml solution for injection SPC no longer supplied –
Tranexamic Acid 500 mg film-coated tablets SPC With or without prescription
Tranexamic Acid 500 mg tablets SPC Prescription only (POM)
Tranexamic Acid Pfizer 100 mg / ml solution for injection SPC –
Tranexamic Acid Rivopharm 500 mg film-coated tablets SPC Prescription only (POM)
Tranexamic Acid Tillomed 500 mg film-coated tablets SPC Prescription only (POM)

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group B02AA02

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.